Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in the United States:
sales of $56.67 billion
of which 57%
Johnson & Johnson
of which 41%
was Medical Devices & Diagnostics), and
of which 29%
was Material Science).
During the year ended December of 2012, sales at
Pfizer Inc. were $58.99 billion.
decrease of 12.5%
versus 2011, when the company's sales were $67.43 billion.
Note that this company discontinued some operations during 2011, which could influence the sales figures.
Contributing to the drop in overall sales was the 31.4% decline
in Primary Care, from $22.67 billion to $15.56 billion.
There were also decreases in sales in
Specialty Care and Oncology (down 6.7% to $15.46 billion)
However, these declines were partially offset by the increase in sales of
Animal Health and Consumer Healthcare (up 3.7% to $7.51 billion)